Connect with us

Hi, what are you looking for?

Investing

Don Hansen: Gold, Silver Stocks “Extraordinarily Undervalued,” Data Shows What’s Next

Focusing on the state of the US monetary system and how it relates to gold, he explained that the gold price is poised to rise, which presents strong opportunities in both gold and silver stocks.

‘We are at a critical point where this is a phenomenal investment opportunity,’ Hansen said.

‘The (stocks) that I like the best are the ones that are not only profitably producing, they’re in the bottom quartile (for costs), they’re in good locations, they have good management — and they have exploration projects within their portfolio which if they develop and get it into a mine would double their production in three years or less.’

Hansen’s current favorite companies are K92 Mining (TSX:KNT,OTCQX:KNTNF), G Mining Ventures (TSX:GMIN,OTCQX:GMINF), Aris Mining (TSX:ARIS,NYSEAMERICAN:ARMN) and Aya Gold & Silver (TSX:AYA,OTCQX:AYASF).

Watch the interview above for more on the topics discussed above, as well as the outlook for the US dollar, thoughts on the BRICS nations and the impact of the US presidential election.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

World biggest companies

Learn Trading With Online Courses, Classes, & Lessons

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 GreatWallStreetPublisher.com